The role of melanin-concentrating hormone and its receptors in energy homeostasis

Frontiers in Endocrinology

Volumn 4, Issue APR, 2013, Pages

  MacNeil, Douglas J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antagonist; Clinical study; KO mice; MCH; MCHR1; Neuropeptide; Obesity; Orexigenic

Indexed keywords

AGOUTI RELATED PROTEIN; ALB 127158; APPETITE STIMULANT; BMS 819881; BMS 830216; G PROTEIN COUPLED RECEPTOR; GW 856464; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE RECEPTOR; MELANIN CONCENTRATING HORMONE RECEPTOR 1; MELANIN CONCENTRATING HORMONE RECEPTOR 1 ANTAGONIST; MELANIN CONCENTRATING HORMONE RECEPTOR 2; NEUROPEPTIDE Y; NGD 4715; OREXIN; THYROID HORMONE; UNCLASSIFIED DRUG;

CONDITIONED TASTE AVERSION; DRUG EFFICACY; DRUG SAFETY; ENERGY METABOLISM; FOOD INTAKE; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; LATERAL HYPOTHALAMUS; NERVE CELL; NEUROANATOMY; NONHUMAN; NUCLEUS ACCUMBENS; OBESITY; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PHASE 1 CLINICAL TRIAL (TOPIC); PHENOTYPE; PHYLOGENY; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN;

EID: 84884195351     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00049     Document Type: Review

References (126)

1. Abbott, C. R., Kennedy, A. R., Wren, A. M., Rossi, M., Murphy, K. G., Seal, L. J., et al. (2003). Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology 144, 3943-3949.
2. Able, S. L., Ivarsson, M., Fish, R. L., Clarke, T. L., McCourt, C., Duckworth, J. M., et al. (2009). Localisation of melanin-concentrating hormone receptor 1 in rat brain and evidence that sleep parameters are not altered despite high central receptor occupancy. Eur. J. Pharmacol. 616, 101-106.
3. Ahnaou, A., Dautzenberg, F. M., Huysmans, H., Steckler, T., and Drinkenburg, W. H. I. M. (2011). Contribution of melanin-concentrating hormone (MCH1) receptor to thermoregulation and sleep stabilization: evidence from MCH1 (-/-) mice. Behav. Brain Res. 218, 42-50.
4. Alon, T., and Friedman, J. M. (2006). Late-onset leanness in mice with targeted ablation of melanin concentrating hormone neurons. J. Neurosci. 26, 389-397.
5. An, S., Cutler, G., Zhao, J. J., Huang, S. G., Tian, H., Li, W., et al. (2001). Identification and characterization of a melanin-concentrating hormone receptor. Proc. Natl. Acad. Sci. U.S.A. 98, 7576-7581.
6. Antal-Zimanyi, I., and Khawaja, X. (2009). The role of melanin-concentrating hormone in energy homeostasis and mood disorders. J. Mol. Neurosci. 39, 86-98.
7. Asakawa, A., Inui, A., Goto, K., Yuzuriha, H., Takimoto, Y., Inui, T., et al. (2002). Effects of agouti-related protein, orexin and melanin-concentrating hormone on oxygen consumption in mice. Int. J. Mol. Med. 10, 523-525.
8. Astrand, A., Bohlooly, Y., Larsdotter, S., Mahlapuu, M., Andersen, H., Tornell, J., et al. (2004). Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R749-R758.
9. Audinot, V., Zuana, O. D., Fabry, N., Ouvry, C., Nosjean, O., Henlin, J. M., et al. (2009). S38151 [p-guanidinobenzoyl-[Des-Gly(10)]-MCH(7-17)] is a potent and selective antagonist at the MCH(1) receptor and has anti-feeding properties in vivo. Peptides 30, 1997-2007.
10. Baird, J. P., Rios, C., Gray, N. E., Walsh, C. E., Fischer, S. G., and Pecora, A. L. (2006). Effects of melanin-concentrating hormone on licking microstructure and brief-access taste responses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, 1265-1274.
11. Baird, J. P., Rios, C., Loveland, J. L., Beck, J., Tran, A., and Mahoney, C. E. (2007). Effects of hindbrain melanin-concentrating hormone and neuropeptide Y administration on licking for water, saccharin, and sucrose solutions. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, 329-343.
12. Balavoine, F., Malabre, P., Alleaume, T., Rey, A., Cherfils, V., Jeanneton, O., et al. (2007). Design and synthesis of novel hydantoin-containing melanin-concentrating hormone receptor antagonists. Bioorg. Med. Chem. Lett. 17, 3754-3759.
13. Bednarek, M. A. (2007). Peptide ligands for the melanin-concentrating hormone (MCH) receptor 1. Curr. Top. Med. Chem. 7, 1425-1432.
14. Bednarek, M. A., Hreniuk, D. L., Tan, C., Palyha, O. C., MacNeil, D. J., Van der Ploeg, L. H., et al. (2002). Synthesis and biological evaluation in vitro of selective, high affinity peptide antagonists of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1. Biochemistry 41, 6383-6390.
15. Bell, C. G., Meyre, D., Samson, C., Boyle, C., Lecoeur, C., Tauber, M., et al. (2005). Association of melanin-concentrating hormone receptor 1 5' polymorphism with early-onset extreme obesity. Diabetes 54, 3049-3055.
16. Bittencourt, J. C. (2011). Anatomical organization of the melanin-concentrating hormone peptide family in the mammalian brain. Gen. Comp. Endocrinol. 172, 185-197.
17. Bjursell, M., Gerdin, A. K., Ploj, K., Svensson, D., Svensson, L., Oscarsson, J., et al. (2006). Melanin-concentrating hormone receptor 1 deficiency increases insulin sensitivity in obese leptin-deficient mice without affecting body weight. Diabetes 55, 725-733.
18. Borowsky, B., Durkin, M. M., Ogozalek, K., Marzabadi, M. R., DeLeon, J., Lagu, B., et al. (2002). Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. 8, 825-830.
19. Bradley, R. L., Mansfield, J. P., Maratos-Flier, E., and Cheatham, B. (2002). Melanin-concentrating hormone activates signaling pathways in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 283, E584-E592.
20. Carpenter, A. J., Al Barazanji, K. A., Barvian, K. K., Bishop, M. J., Britt, C. S., Cooper, J. P., et al. (2006). Novel benzimidazole-based MCH R1 antagonists. Diabetes 16, 4994-5000.
21. Casatti, C. A., Elias, C. F., Sita, L. V., Frigo, L., Furlani, V. C., Bauer, J. A., et al. (2002). Distribution of melanin-concentrating hormone neurons projecting to the medial mammillary nucleus. Neuroscience 115, 899-915.
22. Chagnon, Y. C., Bureau, A., Gendron, D., Bouchard, R. H., Merette, C., Roy, M. A., et al. (2007). Possible association of the pro-melanin-concentrating hormone gene with a greater body mass index as a side effect of the antipsychotic olanzapine. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B, 1063-1069.
23. Chen, X., Mihalic, J., Fan, P., Liang, L., Lindstrom, M., Wong, S., et al. (2012). Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2. Bioorg. Med. Chem. Lett. 22, 363-366.
24. Chen, Y., Hu, C., Hsu, C. K., Zhang, Q., Bi, C., Asnicar, M., et al. (2002). Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology 143, 2469-2477.
25. Cheon, H. G. (2012). "Antiobesity effects of melanin-concentrating hormone receptor 1 (MCH-R1) antagonists," in Appetite Control, Handbook of Experimental Pharmacology, ed. H.-G. Joost (Heidelberg: Springer), 209.
26. Chung, S., Parks, G. S., Lee, C., and Civelli, O. (2011). Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists. J. Mol. Neurosci. 43, 115-121.
27. Della-Zuana, O., Audinot, V., Levenez, V., Ktorza, A., Presse, F., Nahon, J. L., et al. (2012). Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models. Front. Endocrinol. (Lausanne) 3:160. doi:10.3389/fendo.2012.00160
28. Della-Zuana, O., Presse, F., Ortola, C., Duhault, J., Nahon, J. L., and Levens, N. (2002). Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley rats. Int. J. Obes. 26, 1289-1295.
29. Dyck, B., Markison, S., Zhao, L., Tamiya, J., Grey, J., Rowbottom, M. W., et al. (2006). A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic properties. J. Med. Chem. 49, 3753-3756.
30. Elias, C. F., Sita, L. V., Zambon, B. K., Oliveira, E. R., Vasconcelos, L. A., and Bittencourt, J. C. (2008). Melanin-concentrating hormone projections to areas involved in somatomotor responses. J. Chem. Neuroanat. 35, 188-201.
31. Erondu, N., Gantz, I., Musser, B., Suryawanshi, S., Mallick, M., Addy, C., et al. (2006). Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults. Cell Metab. 4, 275-282.
32. Gao, X. B. (2009). Electrophysiological effects of MCH on neurons in the hypothalamus. Peptides 30, 2025-2030.
33. Gehlert, D. R., Rasmussen, K., Shaw, J., Li, X., Ardayfio, P., Craft, L., et al. (2009). Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression. J. Pharmacol. Exp. Ther. 329, 429-438.
34. Georgescu, D., Sears, R. M., Hommel, J. D., Barrot, M., Bolanos, C. A., Marsh, D. J., et al. (2005). The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J. Neurosci. 25, 2933-2940.
35. Ghoussaini, M., Vatin, V., Lecoeur, C., Abkevich, V., Younus, A., Samson, C., et al. (2007). Genetic study of the melanin-concentrating hormone receptor 2 in childhood and adulthood severe obesity. J. Clin. Endocrinol. Metab. 92, 4403-4409.
36. Gibson, W. T., Pissios, P., Trombly, D. J., Luan, J., Keogh, J., Wareham, N. J., et al. (2004). Melanin-concentrating hormone receptor mutations and human obesity: functional analysis. Obes. Res. 12, 743-749.
37. Glick, M., Segal-Lieberman, G., Cohen, R., and Kronfeld-Schor, N. (2009). Chronic MCH infusion causes a decrease in energy expenditure and body temperature, and an increase in serum IGF-1 levels in mice. Endocrine 36, 479-485.
38. Goldstein, C., Schroeder, J. C., Fortin, J. P., Goss, J. M., Schaus, S. E., Beinborn, M., et al. (2010). Two naturally occurring mutations in the type 1 melanin-concentrating hormone receptor abolish agonist-induced signaling. J. Pharmacol. Exp. Ther. 335, 799-806.
39. Gomori, A., Ishihara, A., Ito, M., Mashiko, S., Matsushita, H., Yumoto, M., et al. (2003). Chronic intracerebroventricular infusion of MCH causes obesity in mice. Am. J. Physiol. Endocrinol. Metab. 284, E583-E588.
40. Gomori, A., Ishihara, A., Ito, M., Matsushita, H., Ito, M., Mashiko, S., et al. (2007). Blockade of MCH1 receptor signalling ameliorates obesity and related hepatic steatosis in ovariectomized mice. Br. J. Pharmacol. 151, 900-908.
41. Guesdon, B., Paradis, E., Samson, P., and Richard, D. (2008). Effects of intracerebroventricular and intra-accumbens melanin-concentrating hormone agonism on food intake and energy expenditure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, 469-475.
42. Guyon, A., Conductier, G., Rovere, C., Enfissi, A., and Nahon, J. L. (2009). Melanin-concentrating hormone producing neurons: activities and modulations. Peptides 30, 2031-2039.
43. Hadden, M., Deering, D. M., Henderson, A. J., Surman, M. D., Luche, M., Khmelnitsky, Y., et al. (2010). Synthesis and SAR of 4-aryl-1-(indazol-5-yl)pyridin-2(1H)ones as MCH-1 antagonists for the treatment of obesity. Bioorg. Med. Chem. Lett. 20, 7020-7023.
44. Haga, Y., Mizutani, S., Naya, A., Kishino, H., Iwaasa, H., Ito, M., et al. (2011). Discovery of novel phenylpyridone derivatives as potent and selective MCH1R antagonists. Bioorg. Med. Chem. 19, 883-893.
45. Hawes, B. E., Kil, E., Green, B., O'Neill, K., Fried, S., and Graziano, M. P. (2000). The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways. Endocrinology 141, 4524-4532.
46. Hertzog, D. L., Al Barazanji, K. A., Bigham, E. C., Bishop, M. J., Britt, C. S., Carlton, D. L., et al. (2006). The discovery and optimization of pyrimidinone-containing MCH R1 antagonists. Bioorg. Med. Chem. Lett. 16, 4723-4727.
47. Hervieu, G. J. (2006). Further insights into the neurobiology of melanin-concentrating hormone in energy and mood balances. Expert Opin. Ther. Targets 10, 211-229.
48. Hervieu, G. J., Cluderay, J. E., Harrison, D., Meakin, J., Maycox, P., Nasir, S., et al. (2000). The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat. Eur. J. Neurosci. 12, 1194-1216.
49. Hervieu, G. J., Maulon-Feraille, L., Chambers, J. K., Cluderay, J. E., Wilson, S., Presse, F., et al. (2003). "The melanin-concentrating hormone," in Handbook of Chemical Neuroanatomy; Vol. 20 Peptide Receptors, Part II, eds A. Bjorklund and T. Hokfelt (Amsterdam: Elsevier), 31-101.
50. Hill, J., Duckworth, M., Murdock, P., Rennie, G., Sabido-David, C., Ames, R. S., et al. (2001). Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. J. Biol. Chem. 276, 20125-20129.
51. Huang, C. Q., Baker, T., Schwarz, D., Fan, J., Heise, C. E., Zhang, M., et al. (2005). 1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonists. Bioorg. Med. Chem. Lett. 15, 3701-3706.
52. Ito, M., Gomori, A., Ishihara, A., Oda, Z., Mashiko, S., Matsushita, H., et al. (2003). Characterization of MCH-mediated obesity in mice. Am. J. Physiol. Endocrinol. Metab. 284, 940-945.
53. Ito, M., Gomori, A., Suzuki, J., Tsujioka, S., Sasaki, M., Matsuda, M., et al. (2008). Antagonism of central melanin-concentrating hormone 1 receptor alleviates steatohepatitis in mice. J. Endocrinol. 198, 309-315.
54. Ito, M., Ishihara, A., Gomori, A., Egashira, S., Matsushita, H., Mashiko, S., et al. (2009). Melanin-concentrating hormone 1-receptor antagonist suppresses body-weight gain correlated with high receptor occupancy levels in diet-induced obesity mice. Eur. J. Pharmacol. 624, 77-83.
55. Jeon, J. Y., Bradley, R. L., Kokkotou, E. G., Marino, F. E., Wang, X., Pissios, P., et al. (2006). MCH-/- mice are resistant to aging-associated increases in body weight and insulin resistance. Diabetes 55, 428-434.
56. Johansson, A. (2011). Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists. Expert Opin. Ther. Pat. 21, 905-925.
57. Kamata, M., Yamashita, T., Imaeda, T., Tanaka, T., Terauchi, J., Miyamoto, M., et al. (2011). Discovery, synthesis, and structure-activity relationship of 6-aminomethyl-7,8-dihydronaphthalenes as human melanin-concentrating hormone receptor 1 antagonists. Bioorg. Med. Chem. 19, 5539-5552.
58. Kasai, S., Kamata, M., Masada, S., Kunitomo, J., Kamaura, M., Okawa, T., et al. (2012). Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities. J. Med. Chem. 55, 4336-4351.
59. Kasai, S., Kamaura, M., Kamata, M., Aso, K., Ogino, H., Nakano, Y., et al. (2011). Melanin-concentrating hormone receptor 1 antagonists: synthesis, structure-activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives. Bioorg. Med. Chem. 19, 6261-6273.
60. Kennedy, A. R., Todd, J. F., Stanley, S. A., Abbott, C. R., Small, C. J., Ghatei, M. A., et al. (2001). Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH) release, in vivo and in vitro, via the hypothalamus and the pituitary. Endocrinology 142, 3265-3268.
61. Kokkotou, E., Jeon, J. Y., Wang, X., Marino, F. E., Carlson, M., Trombly, D. J., et al. (2005). Mice with MCH ablation resist diet-induced obesity through strain-specific mechanisms. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R117-R124.
62. Kokkotou, E., Moss, A. C., Torres, D., Karagiannides, I., Cheifetz, A., Liu, S., et al. (2008). Melanin-concentrating hormone as a mediator of intestinal inflammation. Proc. Natl. Acad. Sci. U.S.A. 105, 10613-10618.
63. Kolakowski, L. F. Jr., Jung, B. P., Nguyen, T., Johnson, M. P., Lynch, K. R., Cheng, R., et al. (1996). Characterization of a human gene related to genes encoding somatostatin receptors. FEBS Lett. 398, 253-258.
64. Kowalski, T. J., and Sasikumar, T. (2007). Melanin-concentrating hormone receptor-1 antagonists as antiobesity therapeutics: current status. Biodrugs 21, 311-321.
65. Kowalski, T. J., Spar, B. D., Weig, B., Farley, C., Cook, J., Ghibaudi, L., et al. (2006). Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice. Eur. J. Pharmacol. 535, 182-191.
66. Kym, P. R., Iyengar, R., Souers, A. J., Lynch, J. K., Judd, A. S., Gao, J., et al. (2005). Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists. J. Med. Chem. 48, 5888-5891.
67. Lakaye, B., Minet, A., Zorzi, W., and Grisar, T. (1998). Cloning of the rat brain cDNA encoding for the SLC-1 G protein-coupled receptor reveals the presence of an intron in the gene. Biochim. Biophys. Acta 1401, 216-220.
68. Ludwig, D. S., Tritos, N. A., Mastaitis, J. W., Kulkarni, R., Kokkotou, E., Elmquist, J., et al. (2001). Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J. Clin. Invest. 107, 379-386.
69. MacNeil, D. J., and Bednarek, M. A. (2009). MCH receptor peptide agonists and antagonists. Peptides 30, 2008-2013.
70. Marsh, D. J., Weingarth, D. T., Novi, D. E., Chen, H. Y., Trumbauer, M. E., Chen, A. S., et al. (2002). Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc. Natl. Acad. Sci. U.S.A. 99, 3240-3245.
71. Mashiko, S., Ishihara, A., Gomori, A., Moriya, R., Ito, M., Iwaasa, H., et al. (2005). Antiobesity effect of a melanin-concentrating hormone 1 receptor antagonist in diet-induced obese mice. Endocrinology 146, 3080-3086.
72. Maulon-Feraille, L., Della-Zuana, O., Suply, T., Rovere-Jovene, C., Audinot, V., Levens, N., et al. (2002). Appetite-boosting property of pro-melanin-concentrating hormone131-165 (neuropeptide-glutamic acid-isoleucine) is associated with proteolytic resistance. J. Pharmacol. Exp. Ther. 302, 766-773.
73. McBriar, M. D., Guzik, H., Shapiro, S., Paruchova, J., Xu, R., Palani, A., et al. (2006). Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas. J. Med. Chem. 49, 2294-2310.
74. Mendez-Andino, J. L., Colson, A. O., Meyers, K. M., Mitchell, M. C., Hodge, K., Howard, J. M., et al. (2007). The efficacy and cardiac evaluation of aminomethyl tetrahydronaphthalene ketopiperazines: a novel class of potent MCH-R1 antagonists. Bioorg. Med. Chem. 15, 2092-2105.
75. Mendez-Andino, J. L., and Wos, J. A. (2007). MCH-R1 antagonists: what is keeping most research programs away from the clinic? Drug Discov. Today 12, 972-979.
76. Mihalic, J. T., Fan, P., Chen, X., Chen, X., Fu, Y., Motani, A., et al. (2012). Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition. Bioorg. Med. Chem. Lett. 22, 3781-3785.
77. Mitra, A., Klockars, A., Gosnell, B. A., Le Greves, M., Olszewski, P. K., Levine, A. S., et al. (2012). Expression levels of genes encoding melanin concentrating hormone (MCH) and MCH receptor change in taste aversion, but MCH injections do not alleviate aversive responses. Pharmacol. Biochem. Behav. 100, 581-586.
78. Mori, M., Harada, M., Terao, Y., Sugo, T., Watanabe, T., Shimomura, Y., et al. (2001). Cloning of a novel G protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor. Biochem. Biophys. Res. Commun. 283, 1013-1018.
79. Moriya, M., Kishino, H., Sakuraba, S., Sakamoto, T., Suga, T., Takahashi, H., et al. (2009). Identification of 2-aminobenzimidazoles as potent melanin-concentrating hormone 1-receptor (MCH1R) antagonists. Bioorg. Med. Chem. Lett. 19, 3568-3572.
80. Mul, J. D., la Fleur, S. E., Toonen, P. W., Afrasiab-Middelman, A., Binnekade, R., and Verheij, M. M. (2011). Chronic loss of melanin-concentrating hormone affects motivational aspects of feeding in the rat. PLoS ONE 6:e19600. doi:10.1371/journal.pone.0019600
81. Nagasaki, H., Chung, S., Dooley, C. T., Wang, Z., Li, C., Saito, Y., et al. (2009). The pharmacological properties of a novel MCH(1) receptor antagonist isolated from combinatorial libraries. Eur. J. Pharmacol. 602, 194-202.
82. Nahon, J. L., Presse, F., Bittencourt, J. C., Sawchenko, P. E., and Vale, W. (1989). The rat melanin-concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. Endocrinology 125, 2056-2065.
83. Palani, A., Shapiro, S., McBriar, M. D., Clader, J. W., Greenlee, W. J., Spar, B., et al. (2005). Biaryl ureas as potent and orally efficacious melanin concentrating hormone receptor 1 antagonists for the treatment of obesity. J. Med. Chem. 48, 4746-4749.
84. Pereira-da-Silva, M., De Souza, C. T., Gasparetti, A. L., Saad, M. J. A., and Velloso, L. A. (2005). Melanin-concentrating hormone induces insulin resistance through a mechanism independent of body weight gain. J. Endocrinol. 186, 193-201.
85. Philippe, C., Schirmer, E., Mitterhauser, M., Shanab, K., Lanzenberger, R., Karanikas, G., et al. (2012). Radiosynthesis of [(11)C]SNAP-7941-the first PET-tracer for the melanin concentrating hormone receptor 1 (MCHR1). Appl. Radiat. Isot. 70, 2287-2294.
86. Pissios, P., Bradley, R. L., and Maratos-Flier, E. (2006). Expanding the scales: the multiple roles of MCH in regulating energy balance and other biological functions. Endocr. Rev. 27, 606-620.
87. Pissios, P., and Maratos-Flier, E. (2003). Melanin-concentrating hormone: from fish skin to skinny mammals. Trends Endocrinol. Metab 14, 243-248.
88. Pissios, P., Ozcan, U., Kokkotou, E., Okada, T., Liew, C. W., Liu, S., et al. (2007). Melanin concentrating hormone is a novel regulator of islet function and growth. Diabetes 56, 311-319.
89. Pissios, P., Trombly, D. J., Tzameli, I., and Maratos-Flier, E. (2003). Melanin-concentrating hormone receptor 1 activates extracellular signal-regulated kinase and synergizes with G(s)-coupled pathways. Endocrinology 144, 3514-3523.
90. Qu, D., Ludwig, D. S., Gammeltoft, S., Piper, M., Pelleymounter, M. A., Cullen, M. J., et al. (1996). A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380, 243-247.
91. Rodriguez, M., Beauverger, P., Naime, I., Rique, H., Ouvry, C., Souchaud, S., et al. (2001). Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2. Mol. Pharmacol. 60, 632-639.
92. Rondini, T. A., Rodrigues, B. C., de Oliveira, A. P., Bittencourt, J. C., and Elias, C. F. (2007). Melanin-concentrating hormone is expressed in the laterodorsal tegmental nucleus only in female rats. Brain Res. Bull. 74, 21-28.
93. Sailer, A. W., Sano, H., Zeng, Z., McDonald, T. P., Pan, J., Pong, S. S., et al. (2001). Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc. Natl. Acad. Sci. U.S.A. 98, 7564-7569.
94. Saito, Y., and Nagasaki, H. (2008). The melanin-concentrating hormone system and its physiological functions. Results Probl. Cell Differ. 46, 159-179.
95. Saito, Y., Nothacker, H. P., Wang, Z., Lin, S. H., Leslie, F., and Civelli, O. (1999). Molecular characterization of the melanin-concentrating-hormone receptor. Nature 400, 265-269.
96. Sakamaki, R., Uemoto, M., Inui, A., Asakawa, A., Ueno, N., Ishibashi, C., et al. (2005). Melanin-concentrating hormone enhances sucrose intake. Int. J. Mol. Med. 15, 1033-1039.
97. Sasikumar, T. K., Qiang, L., Burnett, D. A., Greenlee, W. J., Hawes, B. E., Kowalski, T. J., et al. (2006). Novel aminobenzimidazoles as selective MCH-R1 antagonists for the treatment of metabolic diseases. Bioorg. Med. Chem. Lett. 16, 5427-5431.
98. Sasmal, S., Balaji, G., Kanna Reddy, H. R., Balasubrahmanyam, D., Srinivas, G., Kyasa, S., et al. (2012a). Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists. Bioorg. Med. Chem. Lett. 22, 3157-3162.
99. Sasmal, S., Balasubrahmanyam, D., Kanna Reddy, H. R., Balaji, G., Srinivas, G., Cheera, S., et al. (2012b). Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: part 2. Bioorg. Med. Chem. Lett. 22, 3163-3167.
100. Sears, R. M., Liu, R. J., Narayanan, N. S., Sharf, R., Yeckel, M. F., Laubach, M., et al. (2010). Regulation of nucleus accumbens activity by the hypothalamic neuropeptide melanin-concentrating hormone. J. Neurosci. 30, 8263-8273.
101. Segal-Lieberman, G., Bradley, R. L., Kokkotou, E., Carlson, M., Trombly, D. J., Wang, X., et al. (2003). Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc. Natl. Acad. Sci. U.S.A. 100, 10085-10090.
102. Semjonous, N. M., Smith, K. L., Parkinson, J. R., Gunner, D. J., Liu, Y. L., Murphy, K. G., et al. (2009). Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance. Int. J. Obes. (Lond.) 33, 775-785.
103. Semple, G., Tran, T. A., Kramer, B., Hsu, D., Han, S., Choi, J., et al. (2009). Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation. Bioorg. Med. Chem. Lett. 19, 6166-6171.
104. Shearman, L. P., Camacho, R. E., Sloan, S. D., Zhou, D., Bednarek, M. A., Hreniuk, D. L., et al. (2003). Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. Eur. J. Pharmacol. 475, 37-47.
105. Shimada, M., Tritos, N. A., Lowell, B. B., Flier, J. S., and Maratos-Flier, E. (1998). Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396, 670-674.
106. Souers, A. J., Gao, J., Brune, M., Bush, E., Wodka, D., Vasudevan, A., et al. (2005a). Identification of 2-(4-benzyloxyphenyl)-N-[1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity. J. Med. Chem. 48, 1318-1321.
107. Souers, A. J., Gao, J., Wodka, D., Judd, A. S., Mulhern, M. M., Napier, J. J., et al. (2005b). Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. Bioorg. Med. Chem. Lett. 15, 2752-2757.
108. Souers, A. J., Iyengar, R. R., Judd, A. S., Beno, D. W., Gao, J., Zhao, G., et al. (2007). Constrained 7-fluorocarboxychromone-4-aminopiperidine based Melanin-concentrating hormone receptor 1 antagonists: the effects of chirality on substituted indan-1-ylamines. Bioorg. Med. Chem. Lett. 17, 884-889.
109. Suply, T., Della-Zuana, O., Audinot, V., Rodriguez, M., Beauverger, P., Duhault, J., et al. (2001). SLC-1 receptor mediates effect of melanin-concentrating hormone on feeding behavior in rat: a structure-activity study. J. Pharmacol. Exp. Ther. 299, 137-146.
110. Surman, M. D., Freeman, E. E., Grabowski, J. F., Hadden, M., Henderson, A. J., Jiang, G. W., et al. (2010). 5-(Pyridinon-1-yl)indazoles and 5-(furopyridinon-5-yl) indazoles as MCH-1 antagonists. Bioorg. Med. Chem. Lett. 20, 7015-7019.
111. Suzuki, T., Kameda, M., Ando, M., Miyazoe, H., Sekino, E., Ito, S., et al. (2009). Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists. Bioorg. Med. Chem. Lett. 19, 5339-5345.
112. Takekawa, S., Asami, A., Ishihara, Y., Terauchi, J., Kato, K., Shimomura, Y., et al. (2002). T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eur. J. Pharmacol. 438, 129-135.
113. Tan, C. P., Sano, H., Iwaasa, H., Pan, J., Sailer, A. W., Hreniuk, D. L., et al. (2002). Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Genomics 79, 785-792.
114. Tavares, F. X., Al Barazanji, K. A., Bigham, E. C., Bishop, M. J., Britt, C. S., Carlton, D. L., et al. (2006a). Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1. J. Med. Chem. 49, 7095-7107.
115. Tavares, F. X., Al Barazanji, K. A., Bishop, M. J., Britt, C. S., Carlton, D. L., Cooper, J. P., et al. (2006b). 6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist. J. Med. Chem. 49, 7108-7118.
116. Torterolo, P., Sampogna, S., and Chase, M. H. (2009). MCHergic projections to the nucleus pontis oralis participate in the control of active (REM) sleep. Brain Res. 1268, 76-87.
117. Vasudevan, A., Souers, A. J., Freeman, J. C., Verzal, M. K., Gao, J., Mulhern, M. M., et al. (2005a). Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists. Bioorg. Med. Chem. Lett. 15, 5293-5297.
118. Vasudevan, A., Verzal, M. K., Wodka, D., Souers, A. J., Blackburn, C., Che, J. L., et al. (2005b). Identification of aminopiperidine benzamides as MCHr1 antagonists. Bioorg. Med. Chem. Lett. 15, 3412-3416.
119. Vaughan, J. M., Fischer, W. H., Hoeger, C., Rivier, J., and Vale, W. (1989). Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology 125, 1660-1665.
120. Wermter, A. K., Reichwald, K., Buch, T., Geller, F., Platzer, C., Huse, K., et al. (2005). Mutation analysis of the MCHR1 gene in human obesity. Eur. J. Endocrinol. 152, 851-862.
121. Whitlock, B. K., Daniel, J. A., McMahon, C. D., Buonomo, F. C., Wagner, C. G., Steele, B., et al. (2005). Intracerebroventricular melanin-concentrating hormone stimulates food intake in sheep. Domest. Anim. Endocrinol. 28, 224-232.
122. Xu, R., Li, S., Paruchova, J., McBriar, M. D., Guzik, H., Palani, A., et al. (2006). Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists. Bioorg. Med. Chem. 14, 3285-3299.
123. Yao, Y., Fu, L. Y., Zhang, X., and van den Pol, A. N. (2012). Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R815-R824.
124. Yumiko, S., and Nagasaki, H. (2008). "The melanin-concentrating hormone system and its physiological functions," in Orphan G Protein-Coupled Receptors and Novel Neuropeptides, eds O. Civelli and Q.-Y. Zhou (Berlin: Springer), 159-179.
125. Zheng, H., Patterson, L. M., Morrison, C., Banfield, B. W., Randall, J. A., Browning, K. N., et al. (2005). Melanin concentrating hormone innervation of caudal brainstem areas involved in gastrointestinal functions and energy balance. Neuroscience 135, 611-625.
126. Zhou, D., Shen, Z., Strack, A. M., Marsh, D. J., and Shearman, L. P. (2005). Enhanced running wheel activity of both Mch1r- and Pmch-deficient mice. Regul. Pept. 124, 53-63.